期刊文献+

CD147及MMP-2在胃癌中的表达及意义 被引量:3

The Expression and Significance of Matrix Metalloproteinase-2 and CD147 in Gastric Carcinoma
下载PDF
导出
摘要 目的探讨CD147及基质金属蛋白酶-2(MMP-2)在胃癌中表达特点及其生物学行为关系。方法应用免疫组织化学S-P法检测58例胃癌组织及20例正常胃黏膜组织中CD147和MMP-2的表达情况。结果CD147及MMP-2在胃癌组中的阳性表达率分别为77.6%及82.8%,均高于正常胃黏膜组(P<0.01);两者的阳性表达均与胃癌的浸润深度、临床分期及淋巴结转移有关,与分化程度无明显关联;胃癌中CD147及MMP-2的表达具有相关性(P<0.01)。结论胃癌组织中CD147和MMP-2的高表达,可以作为胃癌生物学行为的客观参考指标。 Objective To investigate the relationship between the expressions of CD147 and matrix metalloproteinase-2(MMP-2) and the biology behaviors in gastric cancer. Methods CD147 and MMP-2 expressions were examined by immunohistochemical S-P staining method in 56 cases with gastric cancer and 20 cases with normal gastric tissues. Results The expression rates of CD147 and MMP-2 in gastric carcinoma tissues were 77.6% and 82.8% , respectively, which were significantly higher than those in normal gastric mucosa (P 〈 0.01 ). The expressions of CD147 and MMP-2 were closely correlated with clinical phases, depth of invasion and metastasis of lymph nodes, but no association was observed with pathological grades. There was a significant correlation between the expressions of CD147 and MMP-2 in gastric carcinoma (P 〈 0.01 ). Conclusions The overexpressions of CD147 and MMP-2 may be used as one of the objective marks to estimate the behaviors of gastric carcinoma.
出处 《肿瘤基础与临床》 2007年第1期21-23,共3页 journal of basic and clinical oncology
关键词 胃癌 CD147 MMP-2 免疫组织化学 gastric carcinoma CD147 MMP-2 Immunohistochemical method
  • 相关文献

参考文献11

  • 1Ajani JA,Mansfield PF,Janjan N,et al.Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma[J].J Clin Oncol,2004,22 (14):2774-2780.
  • 2Ishibashi Y,Matsumoto T,Niwa M,et al.CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma[J].Cancer,2004,101 (9):1994-2000.
  • 3Bankfalvi A,Terpe HJ,Breukelmann D,et al.lmmunophenotypic and prognostic analysis of E-cadherin and β-catenin expression during breast carcinogenesis and tumor progression:a comparative study with CD44[J].Histopathology,1999,34(1):25 -34.
  • 4Kleiner DE,Stetler-Stevenson WG.Matrix netalloproteinases and metastasis[J].Cancer Chemother Pharmacol,1999,43 suppl:S42-51.
  • 5Parsons SL,Watson SA,Collins HM,et al.Gelatinase (MMP-2 and MMP-9) expression in gastrointestinal malignancy[J].Br J Cancer.1998,78(11):1495-1502.
  • 6Nomura H,Fujimoto N,Seiki M,et al.Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase-2(gelatinase A) in human gastric carcinomas[J].Int J Cancer,1996,69(1):9-16.
  • 7Sun J,Hemler ME.Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions[J].Cancer Res,2001,61(5):2276-2281
  • 8Guo H,Zucker S,Gordon MK,et al.Stimulation of matrix metalloproteinase production by recombinant extracelluar matrix metalloproteinase inducer from transfected Chinese hamster ovary cells[J].J Biol Chem,1997,272 (1):24-27.
  • 9Sameshima T,Nabeshima K,Toole BP,et al.Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts[J].Cancer Lett,2000,157(2):177 -184.
  • 10Zucker S,Drews M,Conner C,et al.Tissue inhibitor of metalloproteinase-2(TMP22) binds to the catalytic domain of the cell surface receptor,membrane type-matrix metalloproteinase (MT-MMP)[J].J Biol Chem,1998,273(2):1216 -1222.

同被引文献20

  • 1王建红,何松,陈冬梅,谭清和,龚振夏,朱亚芳.Her-2/neu基因过表达与胃癌生物学行为的关系研究[J].临床肿瘤学杂志,2006,11(2):105-109. 被引量:4
  • 2梁启廉,陈小东,王三明,李建文,郑朝晖,黄冰.血管内皮生长因子和抑癌基因P^(33ING1)与胃癌生物学行为的关系[J].第四军医大学学报,2007,28(2):175-178. 被引量:5
  • 3覃山羽,黄刚丁,黄振宁,李信,陶霖,姜海行.胃癌MMP-13,CD44V5表达与肿瘤生物学行为的相关性研究[J].广东医学,2007,28(2):273-275. 被引量:1
  • 4王俊,袁志诚,施洋.p53,Ki67,VEGF和MMP-9在胶质瘤中的表达及意义[J].江苏大学学报(医学版),2007,17(3):228-231. 被引量:10
  • 5Nabcshima K, Iwasaki H, Koga K, et al. Emmprin (basigin/ CD147 ) : matrix tnetalloproteinase modulator and muhifunctional cell recognition molecule that plays a critical role in cancer pro- gression[ J ]. Pathol Int, 2006, 56 (7) : 359 - 67.
  • 6Sun J, Hemler M E. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloprotcinase inducer in- teractions [ J ]. Cancer Res, 2001, 61 (5) : 2276 - 81.
  • 7Cozzi P J, Wang J, Delprado W,et al. MUC1, MUC2,MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer[ J ]. Clin Exp Metastasis, 2005, 22 ( 7 ) :565 - 73.
  • 8Cheng M F, Tzao C, Tsai W C, et al. Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma:conelation with clinicopathological parameters[ J]. Dis Esophagus,2006, 19 (6) :482 -6.
  • 9Sameshima T, Nabeshima K, Toole B P, et al. Expression of emmprin ( CD147), a cell surface inducer of matriax metallopro- teinases in normal human brain and gliomas [ J ]. Int J Cancer, 2000, 88(1 ) :21 -7.
  • 10Tang Y, Nakada M T, Kcsavan P,ct al. Extracellular matrix met- alloproteinase inducer stimulates tumor angiogencsis by elevating vascular endothelial cell growth factor and matrix metalloproteinas- es[J]. Cancer Res, 2005, 65(8) : 3193 -9.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部